Literature DB >> 2536587

Prognostic significance of the presence of human papillomavirus DNA in patients with invasive carcinoma of the cervix.

L A King1, T Tase, L B Twiggs, T Okagaki, J E Savage, L L Adcock, K A Prem, L F Carson.   

Abstract

Cases of invasive carcinoma of the uterine cervix were analyzed to determine whether the presence or absence of human papillomavirus (HPV) DNA in the neoplasms was a contributing factor to their outcome. The presence of HPV DNA was evaluated using in situ hybridization on formalin-fixed, paraffin-embedded tissue sections. Eighty-five patients with cervical carcinoma who had been surgically evaluated were included in the study. Data from these patients was analyzed retrospectively to determine survival, recurrence, presence of nodal metastases, tumor grade, mode of therapy, peritoneal fluid cytologic results, and age in relation to presence or absence of HPV DNA. No significant statistical differences were found between the HPV-16-positive, HPV-18-positive, and HPV DNA-negative patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536587     DOI: 10.1002/1097-0142(19890301)63:5<897::aid-cncr2820630517>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.

Authors:  C Bleul; M Müller; R Frank; H Gausepohl; U Koldovsky; H N Mgaya; J Luande; M Pawlita; J ter Meulen; R Viscidi
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

2.  Human papillomavirus and c-myc/c-erbB2 in uterine and vulvar lesions.

Authors:  K Milde-Langosch; G Becker; T Löning
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Adenoid cystic carcinoma of the uterine cervix.

Authors:  Masakazu Nishida; Kaei Nasu; Noriyuki Takai; Isao Miyakawa; Kenji Kashima
Journal:  Int J Clin Oncol       Date:  2005-06       Impact factor: 3.402

4.  Human papillomavirus and cervical intraepithelial neoplasia in women who subsequently had invasive cancer.

Authors:  D Caussy; L D Marrett; A J Worth; M McBride; W E Rawls
Journal:  CMAJ       Date:  1990-02-15       Impact factor: 8.262

5.  Human papillomavirus DNA and p53 status in stage IB bulky cervical cancer.

Authors:  C A Chen; T M Chen; C C Wu; C F Chang; C Y Hsieh
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

6.  Metastatic conversion of cells by expression of human papillomavirus type 16 E6 and E7 genes.

Authors:  L Chen; S Ashe; M C Singhal; D A Galloway; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

7.  Detection of human papillomavirus in vulvar carcinoma. A study by in situ hybridisation.

Authors:  A W Brandenberger; R Rüdlinger; W Hänggi; N A Bersinger; E Dreher
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

8.  Genetic alterations on chromosome 17p associated with response to radiotherapy in bulky cervical cancer.

Authors:  Y Harima; S Shirahama; K Harima; S Aoki; T Ohnishi; Y Tanaka
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

9.  Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinoma.

Authors:  Ruth Holm; Irene Kraus; Hanne Skomedal; Anita Langerød; Gunnar B Kristensen; Heidi Lyng
Journal:  Open Virol J       Date:  2008-10-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.